PDF) Prognostic Digital Biomarkers for MCI due to AD
Altoida CEO and key executive team | Craft.co
Ioannis Tarnanas, PhD, MSc | Global Brain Health Institute
EIT Health - Congratulations to Altoida for raising $6.3M Series A to Predict Alzheimer's Disease Risk Using Artificial Intelligence, Machine Learning and Augmented Reality. Altoida CSO – Dr. Ioannis Tarnanas was the
EIT Health wins 3 of 5 top European awards for innovations to treat cancer, predict Alzheimer's and detect stroke risk - EIT Health
Altoida Chief Science Officer Ioannis Tarnanas to Keynote at Worldwebforum - Jan. 14, 2020 - Altoida
Altoida raises $6.3M to provide digital Alzheimer's biomarkers in augmented reality | FierceBiotech
Ioannis Tarnanas | Nature Portfolio Health Community
Ioannis Tarnanas - Worldwebforum
Ioannis Tarnanas (@ITarnanas) | Twitter
Device to Spot Alzheimer's in Adults With Mild Dementia Noted by FDA
Altoida, Inc. - Employees, Board Members, Advisors & Alumni
Altoida secures funding and research partnership with Eisai Innovation – Venturelab
Altoida - Diagnosing Alzheimer's Disease 5 years prior to it's onset using Augmented Reality on your iPhone | Startup Ranking
Ioannis Tarnanas (@ITarnanas) | Twitter
EIT Health - Ioannis Tarnanas is the winner of #EIT Innovators Award. He is CSO for Altoida- makers of ADPS, which can tell if someone will develop Alzheimer's disease within 6 years,
Altoida Begins Its Journey To Use AI In Neuroscience With A $6.3M Funding Round — AI Daily - Artificial Intelligence News
Ioannis Tarnanas - Worldwebforum
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases | TechCrunch
Ioannis Tarnanas - Worldwebforum
Altoida Raises $6.3 Million for Early, AI-Test for Alzheimer's Disease
World Dementia Council" debates on Technology; with Ioannis Tarnanas CEO of Altoida - Alpana Ventures
Ioannis Tarnanas - Worldwebforum
Altoida Partners to Test Precision Device in Detecting Parkinson's
